Tag: lung cancer screening market

  • Global Lung Cancer Screening Market Forecast 2029: Size, Share, and Competitive Landscape

    Global Lung Cancer Screening Market Forecast 2029: Size, Share, and Competitive Landscape

    Uncover key drivers, emerging technologies, and competitive movements shaping the lung cancer screening market from 2025–2034 with trusted insights from The Business Research Company

    How Is The Lung Cancer Screening Market Expected To Grow In Terms Of Size?

    The lung cancer screening market size has experienced strong expansion in recent years. It is anticipated to increase from $3.03 billion in 2024 to $3.33 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.9%. The market’s historical growth can be attributed to factors such as the rising prevalence of tobacco consumption, growing awareness about early cancer detection, increasing government initiatives and screening programs, a rising geriatric population, and the increasing penetration of private diagnostic centers.

    The lung cancer screening market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $4.79 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.5%. This growth during the forecast period is attributable to the increasing prevalence of air pollution and occupational risks, mounting clinical evidence underscoring the benefits of early screening, expanded access to insurance coverage, escalating urbanization and evolving lifestyles, and heightened investments in radiology infrastructure. Significant trends expected in the forecast period include the adoption of cloud-based imaging platforms, advancements in radiomics and image analytics, innovations in portable and point-of-care imaging devices, the integration of decision support systems into radiology workflows, and breakthroughs in non-invasive biomarker-based screening methods.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27331&type=smp

    What Market Forces Are Contributing To The Growth Of The Lung Cancer Screening Market?

    The increasing prevalence of smoking is projected to stimulate the expansion of the lung cancer screening market in the future. Smoking is defined as the act of drawing smoke, typically from tobacco, into the mouth and lungs from burning substances. The escalation in smoking rates is attributed to heightened stress levels, prompting more individuals to adopt smoking as a way to cope. Lung cancer screening offers significant utility in addressing the growing smoking trends by enabling the prompt detection of smoking-related health hazards, which can motivate individuals to cease smoking and contribute to broader public health campaigns aimed at reducing tobacco use. For instance, in September 2023, the Office for National Statistics, a UK-based government agency, reported that in Great Britain, roughly 4.5 million adults, or 8.7% of the population, indicated using e-cigarettes either daily or occasionally in 2022, marking an increase from 7.7% in 2021. Therefore, the rising smoking rates are serving as a primary driver for the growth of the lung cancer screening market.

    How Is The Lung Cancer Screening Market Segmented Across Key Categories?

    The lung cancer screening market covered in this report is segmented

    1) By Diagnosis Type: Low Dose Spiral Computed Tomography Scan, Chest-X-Ray

    2) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer

    3) By Age Group: 50 And Older, Below 50

    4) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

    Subsegments:

    1) By Low Dose Spiral Computed Tomography Scan: Screening, Diagnostic, Follow-Up

    2) By Chest X-Ray: Posterior Anterior, Lateral, Portable

    What Key Trends Are Driving Growth In The Lung Cancer Screening Market?

    Key companies operating in the lung cancer screening market are concentrating on developing sophisticated solutions, such as normal flagging, to improve diagnostic precision, lessen false positives, and enhance the early detection of cancerous nodules. Normal flagging represents a technological feature within lung cancer screening that automatically identifies and flags scans without abnormal findings, which helps prioritize cases needing further review. For example, in May 2025, Lunit Inc., a medical technology company based in South Korea, unveiled INSIGHT CXR4, its next-generation artificial intelligence (AI)-powered chest X-ray analysis solution, which has obtained CE MDR certification for deployment across Europe. This solution, designed to assist radiologists by improving diagnostic accuracy and workflow efficiency, identifies 12 chest abnormalities, including lung nodules, pneumonia, and acute bone fractures, and integrates features such as current-prior image comparison to support early disease detection and clinical decision-making.

    Who Are The Major Stakeholders Operating In The Lung Cancer Screening Market?

    Major companies operating in the lung cancer screening market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, AstraZeneca Plc, Abbott Laboratories Inc., Canon Inc., Medtronic Plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Shimadzu Corporation, NeoGenomics Laboratories Inc., Freenome Holdings Inc., Biodesix Inc., Lunit Inc., Infervision, Riverain Technologies, VisionGate, and Delfi Diagnostics Inc.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/lung-cancer-screening-global-market-report

    How Do Regional Dynamics Influence The Lung Cancer Screening Market Performance?

    North America was the largest region in the lung cancer screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=27331&type=smp

    Browse Through More Reports Similar to the Global Lung Cancer Screening Market 2025, By The Business Research Company

    Fraud Detection And Prevention Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/fraud-detection-and-prevention-global-market-report

    Payment Monitoring Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/payment-monitoring-global-market-report

    Ecommerce Fraud Detection And Prevention Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/ecommerce-fraud-detection-and-prevention-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Lung Cancer Screening Market Overview: Trends Shaping Growth to 2029

    Global Lung Cancer Screening Market Overview: Trends Shaping Growth to 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Is The Expected Total Market Size Of The Lung Cancer Screening Industry By The Forecast Year 2029?

    The lung cancer screening market size has demonstrated significant expansion in recent years. This market is expected to increase from $3.03 billion in 2024 to $3.33 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.9%. Historically, this market growth has been primarily influenced by factors such as the increasing prevalence of tobacco consumption, heightened awareness concerning early cancer detection, a surge in government initiatives and screening programs, a growing geriatric population, and the expanding presence of private diagnostic centers.

    The lung cancer screening market is anticipated to experience robust expansion over the coming years. Its valuation is projected to reach $4.79 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.5%. This projected growth is driven by several factors, including the increasing impact of air pollution and workplace hazards, accumulating clinical proof for the advantages of early detection, wider access to insurance plans, evolving urbanization and shifts in lifestyle, and greater financial commitment to radiology facilities. Key trends anticipated during this period involve the incorporation of cloud-based imaging solutions, progress in radiomics and image analytics, innovations in mobile and point-of-care imaging technologies, the embedding of decision support systems into radiology procedures, and breakthroughs in non-invasive biomarker-based screening methods.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27331&type=smp

    Which Drivers Are Supporting Growth Of The Lung Cancer Screening Market?

    The escalating prevalence of smoking is projected to drive the growth of the lung cancer screening market in the future. Smoking involves the act of inhaling smoke from burning materials, typically tobacco, through the mouth and into the lungs. This increase in smoking rates stems from heightened stress levels, prompting more individuals to adopt smoking as a coping mechanism. Lung cancer screening contributes to addressing these rising smoking rates by enabling the early detection of health risks associated with smoking, which can motivate people to quit and support broader public health efforts aimed at reducing tobacco use. For instance, in September 2023, the Office for National Statistics, a UK-based government agency, reported that in Great Britain, approximately 4.5 million adults, or 8.7% of the population, used e-cigarettes either daily or occasionally in 2022, indicating an increase from 7.7% in 2021. Therefore, the rising smoking rates are propelling the expansion of the lung cancer screening market.

    Which Key Segments Fueling The Lung Cancer Screening Market?

    The lung cancer screening market covered in this report is segmented

    1) By Diagnosis Type: Low Dose Spiral Computed Tomography Scan, Chest-X-Ray

    2) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer

    3) By Age Group: 50 And Older, Below 50

    4) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

    Subsegments:

    1) By Low Dose Spiral Computed Tomography Scan: Screening, Diagnostic, Follow-Up

    2) By Chest X-Ray: Posterior Anterior, Lateral, Portable

    Which Market Trends Are Creating New Opportunities In The Lung Cancer Screening Industry?

    Major companies in the lung cancer screening market are focusing on developing advanced solutions, such as normal flagging, to boost diagnostic accuracy, reduce false positives, and improve the early detection of cancerous nodules. Normal flagging is a technological feature in lung cancer screening that automatically identifies and marks scans showing no abnormal findings, thereby helping to prioritize cases that require further review. For instance, in May 2025, Lunit Inc., a South Korea-based medical technology company, introduced INSIGHT CXR4, its next-generation artificial intelligence (AI)-powered chest X-ray analysis solution, which has now achieved CE MDR certification for deployment across Europe. Created to assist radiologists with better diagnostic accuracy and workflow efficiency, the solution detects 12 chest abnormalities, including lung nodules, pneumonia, and acute bone fractures, and incorporates features such as current-prior image comparison to support early disease detection and clinical decision-making.

    Which Leading Companies Dominate The Lung Cancer Screening Market Share?

    Major companies operating in the lung cancer screening market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, AstraZeneca Plc, Abbott Laboratories Inc., Canon Inc., Medtronic Plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Shimadzu Corporation, NeoGenomics Laboratories Inc., Freenome Holdings Inc., Biodesix Inc., Lunit Inc., Infervision, Riverain Technologies, VisionGate, and Delfi Diagnostics Inc.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/lung-cancer-screening-global-market-report

    Which Region Currently Holds The Largest Share Of The Lung Cancer Screening Market?

    North America was the largest region in the lung cancer screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Lung Cancer Screening Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=27331&type=smp

    Browse Through More Reports Similar to the Global Lung Cancer Screening Market 2025, By The Business Research Company

    Fraud Detection And Prevention Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/fraud-detection-and-prevention-global-market-report

    Financial Fraud Detection Software Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/financial-fraud-detection-software-global-market-report

    Payment Monitoring Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/payment-monitoring-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model